Exploring potential applications of measles and rubella microarray patches (MR-MAPs): use case identification.

ABSTRACT:

Introduction

Innovative vaccine products will be critical in helping to address the existing implementation barriers that have prevented the achievement of the measles and rubella (MR) vaccine coverage targets. Overcoming those barriers will be necessary to achieve the "Immunization Agenda 2030" goals. Microarray patches (MAPs), an innovative needle-free delivery device currently in clinical development, can be a potential game changer in this respect and contribute to the equitable delivery of vaccines in low- and middle-income countries and pandemic preparedness and response. Developing in-depth knowledge of the most desired and impactful uses of MRMAPs can prove critical to identifying the critical attributes of the target product profile, informing policy and adoption decisions

SUBMITTER: Malvolti S 

PROVIDER: S-EPMC10291693 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature